A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non small cell lung cancer (NSCLC) Meeting Abstract
| Authors: | Owen, D.; Bunn, P. Jr; Johnson, B.; Kwiatkowski, D.; Kris, M.; Wistuba, I.; Gandhi, M.; Phan, S.; Shames, D.; Schulze, K.; Bernaards, C.; Aisner, D.; Chaft, J.; Gainor, J.; Lee, J.; Minna, J.; Mino-Kenudson, M.; Garcia-Prieto, C.; Rusch, V.; Sabichi, A.; Villaruz, L.; Wozniak, A.; Carbone, D. |
| Abstract Title: | A phase II study of atezolizumab as neoadjuvant and adjuvant therapy in patients (pts) with resectable non small cell lung cancer (NSCLC) |
| Meeting Title: | IASLC 17th World Conference on Lung Cancer |
| Keywords: | immunotherapy; non-small cell lung cancer; neoadjuvant; pd-l1 |
| Journal Title: | Journal of Thoracic Oncology |
| Volume: | 12 |
| Issue: | 1 Suppl. |
| Meeting Dates: | 2016 Dec 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1556-0864 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2017-01-01 |
| Start Page: | S1082 |
| Language: | English |
| ACCESSION: | WOS:000413055802327 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.jtho.2016.11.1512 |
| Notes: | Meeting Abstract: P2.06-019 -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
